Peripheral T-Cell Lymphoma Latest Advances

Single-agent gemcitabine enabling successful bridging to allogeneic haematopoietic stem-cell transplantation in refractory peripheral T-cell lymphoma, not otherwise specified.

Journal: BMJ case reports

Published: June 23, 2026

Kaposi's varicelliform eruption presenting with thick facial crusting.

Journal: Internal medicine (Tokyo, Japan)

Published: June 17, 2026

Immunosuppression-Associated Peripheral T-Cell Lymphoma.

Journal: The New England journal of medicine

Published: June 15, 2026

Cow hooves and clover: Unusual morphology of peripheral T-cell lymphoma.

Journal: British journal of haematology

Published: June 03, 2026

Secondary cutaneous involvement in peripheral T-cell lymphoma: Diagnostic frameworks, staging integration, and therapeutic implications.

Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Published: June 02, 2026

Expression of GATA3 in Patients with Peripheral T-Cell Lymphoma and Its Clinical Significance

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 02, 2026

A single-centre analysis of nodal peripheral T-cell lymphomas in Southern Vietnam: Insights from the WHO 2022 classification.

Journal: The Malaysian journal of pathology

Published: April 30, 2026

Innovative approaches for managing relapsed or refractory peripheral T-cell lymphoma.

Journal: Expert opinion on pharmacotherapy

Published: April 28, 2026

Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 22, 2026

Unmasking peripheral T-cell lymphoma in dermatomyositis with anti-PM/Scl-100 and anti-Mi-2 positivity: a case-based review.

Journal: Rheumatology international

Published: April 20, 2026

Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: March 31, 2026

Aggressive GATA-3 Positive Primary Cutaneous Peripheral T-Cell Lymphoma - Not Otherwise Specified Masquerading as CD-4 Positive Small/Medium T-Cell Lymphoproliferative Disorder: Where is the Line of Delineation?

Journal: Indian journal of dermatology

Published: March 26, 2026

Peripheral T-Cell Lymphoma Latest Advances

Find the Latest Research About Peripheral T-Cell Lymphoma

Single-agent gemcitabine enabling successful bridging to allogeneic haematopoietic stem-cell transplantation in refractory peripheral T-cell lymphoma, not otherwise specified.

Single-agent gemcitabine enabling successful bridging to allogeneic haematopoietic stem-cell transplantation in refractory peripheral T-cell lymphoma, not otherwise specified.

Kaposi's varicelliform eruption presenting with thick facial crusting.

Kaposi's varicelliform eruption presenting with thick facial crusting.

Immunosuppression-Associated Peripheral T-Cell Lymphoma.

Immunosuppression-Associated Peripheral T-Cell Lymphoma.

Cow hooves and clover: Unusual morphology of peripheral T-cell lymphoma.

Cow hooves and clover: Unusual morphology of peripheral T-cell lymphoma.

Secondary cutaneous involvement in peripheral T-cell lymphoma: Diagnostic frameworks, staging integration, and therapeutic implications.

Secondary cutaneous involvement in peripheral T-cell lymphoma: Diagnostic frameworks, staging integration, and therapeutic implications.

Expression of GATA3 in Patients with Peripheral T-Cell Lymphoma and Its Clinical Significance

Expression of GATA3 in Patients with Peripheral T-Cell Lymphoma and Its Clinical Significance

A single-centre analysis of nodal peripheral T-cell lymphomas in Southern Vietnam: Insights from the WHO 2022 classification.

A single-centre analysis of nodal peripheral T-cell lymphomas in Southern Vietnam: Insights from the WHO 2022 classification.

Innovative approaches for managing relapsed or refractory peripheral T-cell lymphoma.

Innovative approaches for managing relapsed or refractory peripheral T-cell lymphoma.

Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.

Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma.

Unmasking peripheral T-cell lymphoma in dermatomyositis with anti-PM/Scl-100 and anti-Mi-2 positivity: a case-based review.

Unmasking peripheral T-cell lymphoma in dermatomyositis with anti-PM/Scl-100 and anti-Mi-2 positivity: a case-based review.

Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report.

Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report.

Aggressive GATA-3 Positive Primary Cutaneous Peripheral T-Cell Lymphoma - Not Otherwise Specified Masquerading as CD-4 Positive Small/Medium T-Cell Lymphoproliferative Disorder: Where is the Line of Delineation?

Aggressive GATA-3 Positive Primary Cutaneous Peripheral T-Cell Lymphoma - Not Otherwise Specified Masquerading as CD-4 Positive Small/Medium T-Cell Lymphoproliferative Disorder: Where is the Line of Delineation?